Insider filing · ABBV
Scott T Reents sold $3.7M of AbbVie (ABBV)
Executed Mar 14 2025, disclosed Mar 18 2025, 4 days later.
Value, as filed
$3.7M
17,644 sh × $212.34
Executed
Mar 14 2025
the trade date, as filed
Disclosed
Mar 18 2025
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SR
Scott T Reents
EVP, CHIEF FINANCIAL OFFICER
profile →
Scott T Reents (EVP, CHIEF FINANCIAL OFFICER) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in AbbVie Inc. (ABBV). The largest single filing was $3.7M of ABBV (17,644 sh × $212.34, as filed), executed Mar 14 2025.
The name
ABBV
AbbVie Inc.
ABBV · Healthcare · 41 filings in 24 months
ticker →
Healthcare · AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→